Lactulose vs Polyethylene Glycol for Treatment of Hepatic Encephalopathy-Reply.
Annette C. and Harold C. Simmons Transplant Institute, Baylor University Medical Center, Dallas, Texas.
Robert S
RS
Rahimi
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas3Parkland Memorial Hospital, Parkland Health and Hospital System, Dallas, Texas.
Jennifer A
JA
Cuthbert
Department of Internal Medicine, Medical University of South Carolina, Charleston, South Carolina.
Don C
DC
Rockey
D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000188:drug therapy*; D006801:Humans; D007792:Lactulose / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D013501:Surface-Active Agents / Q000627:therapeutic use*
D005765:Gastrointestinal Agents; D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D007792:Lactulose